Company intelligence / Profile preview

Lifordi

Basel, Basel-Stadt, Switzerland

Ownership: Private
Development stage: Other

Overview

Lifordi is a Swiss digital health company headquartered in Basel that provides advanced technology solutions for the life sciences and healthcare sectors. The company specializes in decentralized clinical trials (DCT), patient engagement, and the integration of digital biomarkers into clinical research. Lifordi's platform is designed to improve the efficiency of clinical data collection while prioritizing the patient experience through user-friendly digital interfaces. By bridging the gap between traditional clinical research and modern digital tools, Lifordi supports pharmaceutical companies in accelerating their development timelines. The firm is notably led by high-profile industry expertise, focusing on the digital transformation of the drug development lifecycle.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Lifordi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifordi.

Explore the full profile